ANTIGEN RECOGNITION BY GAMMA DELTA T CELLS
ANTIGEN RECOGNITION BY GAMMA DELTA T CELLS
批准号:
6171153
负责人:
CRAIG T MORITA
金额:
$26.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-20 至 2003-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): T-cells are divided
into two subsets based on their expression of ab or gd T-cell antigen
receptors. Since gd T-cells expand in patients during a number of
infections (up to 50% of all T-cells in the peripheral blood), they are
likely to be involved in human immunity to infection. Moreover, murine gd
T-cells play critical roles in immunity to Mycobacterium tuberculosis since
mice lacking gd T-cells succumb to infection. Gd T-cells may also be
important in autoimmunity since they expand in the tissues of patients with
certain autoimmune diseases. Support for this hypothesis comes from murine
models for lupus, autoimmune diabetes, and collagen-induced arthritis, where
gd T-cells play regulatory roles limiting autoimmune ab T-cell responses.
However, the antigens that activate these regulatory gd T-cells have not
been identified and only a few examples of antigens recognized by gd T-cells
have been molecularly defined. Recently, the investigator found that the
predominant subset of human gd T-cells is stimulated by the staphylococcal
superantigen, SEA, and by nonpeptide prenyl pyrophosphate compounds such as
isopentenyl pyrophosphate. Prenyl pyrophosphates are essential precursors
for isoprenoid compounds that are made in bacteria and man and thus
represent both potential foreign as well as self antigens that could
activate immune or autoimmune gd T-cells. Gd T-cell recognition of these
nonpeptide antigens is mediated by the Vg2Vd2 TCR and utilizes a novel
extracellular presentation pathway that does not involve known antigen
presenting molecules.
The investigators propose to further define recognition by the gd TCR and
determine its functional significance. In Aim 1 Vg2Vd2 TCR binding to the
prenyl pyrophosphate antigens and to the SEA superantigen will be measured.
In Aim 2, the antigen presenting molecule for the nonpeptide antigens will
be identified by characterizing the antigen presenting cell protein that
reacts with a photoaffinity analog of farnesyl pyrophosphate or with mAbs.
In Aim 3, the structural and functional relevance of bacterial 262 and 276
Dalton unconjugated and nucleotide-conjugated prenyl pyrophosphate antigens
will be determined. In Aim 4 the role of Vg2Vd2+ T-cells in the in vivo
immune response to Mycobacterium bovis BCG infections in rhesus monkey
animal model will be evaluated. These basic studies will provide insights
into the mechanisms of antigen recognition by human gd T-cells and should
help clarify their role in immunity and autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic Engineering of Bacteria for Cancer Immunotherapy by Gamma Delta T Cells
-
批准号:10516094
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:CRAIG T MORITA
-
依托单位:
Metabolic Engineering of Bacteria for Cancer Immunotherapy by Gamma Delta T Cells
-
批准号:8143090
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:CRAIG T MORITA
-
依托单位:
Metabolic Engineering of Bacteria for Cancer Immunotherapy by Gamma Delta T Cells
-
批准号:8598011
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:CRAIG T MORITA
-
依托单位:
Metabolic Engineering of Bacteria for Cancer Immunotherapy by Gamma Delta T Cells
-
批准号:10412920
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:CRAIG T MORITA
-
依托单位:
Metabolic Engineering of Bacteria for Cancer Immunotherapy by Gamma Delta T Cells
-
批准号:10057222
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:CRAIG T MORITA
-
依托单位:
Metabolic Engineering of Bacteria for Cancer Immunotherapy by Gamma Delta T Cells
-
批准号:8391627
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:CRAIG T MORITA
-
依托单位:
Metabolic Engineering of Bacteria for Cancer Immunotherapy by Gamma Delta T Cells
-
批准号:9206071
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:CRAIG T MORITA
-
依托单位:
Metabolic Engineering of Bacteria for Cancer Immunotherapy by Gamma Delta T Cells
-
批准号:8922337
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:CRAIG T MORITA
-
依托单位:
Gamma Delta T cell Recognition in Tularemia
-
批准号:7945860
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2009
-
负责人:CRAIG T MORITA
-
依托单位:
Gamma Delta T Cell Recognition in Tularemia
-
批准号:7641850
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2008
-
负责人:CRAIG T MORITA
-
依托单位:
Immunotherapy with Gamma Delta T Cells for B Cell Tumors
-
批准号:6906987
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2005
-
负责人:CRAIG T MORITA
-
依托单位:
Immunotherapy with Gamma Delta T Cells for B Cell Tumors
-
批准号:7246616
-
项目类别:
-
资助金额:$22.1万
-
财政年份:2005
-
负责人:CRAIG T MORITA
-
依托单位:
Immunotherapy with Gamma Delta T Cells for B Cell Tumors
-
批准号:7116876
-
项目类别:
-
资助金额:$22.76万
-
财政年份:2005
-
负责人:CRAIG T MORITA
-
依托单位:
Immunotherapy with Gamma Delta T Cells for B Cell Tumors
-
批准号:7452501
-
项目类别:
-
资助金额:$22.1万
-
财政年份:2005
-
负责人:CRAIG T MORITA
-
依托单位:
ANTIGEN RECOGNITION BY GAMMA DELTA T CELLS
-
批准号:6079019
-
项目类别:
-
资助金额:$19.57万
-
财政年份:1998
-
负责人:CRAIG T MORITA
-
依托单位:
ANTIGEN RECOGNITION BY GAMMA DELTA T CELLS
-
批准号:6375151
-
项目类别:
-
资助金额:$27.19万
-
财政年份:1998
-
负责人:CRAIG T MORITA
-
依托单位:
Antigen Recognition by Gamma Delta T Cells
-
批准号:7116880
-
项目类别:
-
资助金额:$42.06万
-
财政年份:1998
-
负责人:CRAIG T MORITA
-
依托单位:
Antigen Recognition by Gamma Delta T Cells
-
批准号:7276642
-
项目类别:
-
资助金额:$42.2万
-
财政年份:1998
-
负责人:CRAIG T MORITA
-
依托单位:
Antigen Recognition by Gamma Delta T Cells
-
批准号:6685434
-
项目类别:
-
资助金额:$42.64万
-
财政年份:1998
-
负责人:CRAIG T MORITA
-
依托单位:
Antigen Recognition by Gamma Delta T Cells
-
批准号:6924536
-
项目类别:
-
资助金额:$45.23万
-
财政年份:1998
-
负责人:CRAIG T MORITA
-
依托单位:
海外基金